Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are currently living in the US or Canada at the time of joining the study
- People who are currently pregnant
- People who are between 18 and 50 years old at the time of joining the study
- People who have been diagnosed with Inflammatory Bowel Disease (IBD) — such as ulcerative colitis, Crohn's disease, or a related bowel condition — confirmed by a doctor
- People who have signed and dated a consent form, or given verbal consent (if allowed by the reviewing ethics board), showing they have been informed about the study
- People who agree to allow their healthcare provider to share their medical information with the registry
- People who provide their own contact details and their healthcare provider's contact details
For one group in the study only:
- People who have taken IBD medication during their pregnancy
Who may not be able to join:
- People who have been exposed to the medication methotrexate at any point during their pregnancy
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ronna L Chan, PhD, MPH, PPD, Part of Thermo Fisher Scientific
Phone: 800-616-3791
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Major congenital malformation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.